Liver

2024 - 3 - 3

Discover How the Liver Split Impacts Regeneration in Rats

AI in Healthcare - Cancer Treatment - Liver - Liver Cancer - Liver Health - Liver Transplant - Medical Advancements

Uncover the secrets behind liver parenchyma transection and its role in accelerating liver remnant regeneration in rats!

The liver, a vital organ responsible for detoxification and metabolism, plays a crucial role in the body's overall well-being. Recent research has delved into the impact of the extent and location of liver split on the regeneration of future liver remnants in rats. By investigating the role and mechanism of liver parenchyma transection, scientists aim to understand how this process accelerates the regeneration of liver tissue in rats with portal vein issues.

The findings of the study shed light on the fascinating mechanisms at play within the liver. The extent and location of liver split have been identified as key factors influencing the rate of regeneration in rats. Understanding these factors could have significant implications for liver surgery and transplant procedures, potentially improving patient outcomes and recovery times.

Furthermore, exploring the intricate relationship between liver parenchyma transection and the regeneration of future liver remnants offers valuable insights into the body's remarkable ability to heal and adapt. This research not only advances our understanding of liver physiology but also opens doors to innovative approaches in liver treatment and surgical techniques.

Impact of the extent and location of liver split on future liver remnant ... (Physician's Weekly)

To investigate the role and mechanism of liver parenchyma transection in accelerating the regeneration of future liver remnants in rats with portal vein ...

Post cover
Image courtesy of "The Japan News"

World's 1st Living-donor Lung-liver Transplant Successful at Kyoto ... (The Japan News)

KYOTO โ€” Kyoto University Hospital announced Monday that it had succeeded in the world's first combined lung-liver transplantation from living donors.

Post cover
Image courtesy of "ISRAEL21c"

AI-guided technique will be gamechanger for liver cancer - ISRAEL21c (ISRAEL21c)

Techsomed's thermal ablation therapy, a minimally invasive procedure for small tumors, has huge benefits over surgery or chemotherapy for patients and is a ...

Post cover
Image courtesy of "New Straits Times Online"

#Showbiz: Miji of Cromok fame battling Stage 4 liver cancer (New Straits Times Online)

KUALA LUMPUR: Former drummer of Cromok, local thrash metal band popular in the 1990s, Tarmizi Mokhtar a.k.a. Miji has been hospitalised due to Stage 4 liver ...

Post cover
Image courtesy of "STAT"

Longer treatment gave better liver outcomes for MASH patients ... (STAT)

Patients treated longer with the drug, efruxifermin, saw sustained reductions in the liver scarring that characterizes MASH.

Post cover
Image courtesy of "Reuters"

Akero's drug reduces fatty liver scarring in mid-stage trial (Reuters)

Akero Therapeutics' drug to treat a type of fatty liver disease helped significantly reduce scarring after nearly two years in a study, it said on Monday, ...

UPDATE 1-Akero's lead drug helps reduce scarring in fatty liver ... (Yahoo Finance)

Akero Therapeutics said on Monday its lead experimental drug to treat a type of fatty liver disease helped reduce scarring after 96 weeks, meeting the main ...

Non-alcoholic fatty liver disease in Tanzania: prevalence ... (BMC Gastroenterology)

Non-alcoholic fatty liver disease (NAFLD), which is closely associated with metabolic syndrome (MetS), is rarely reported in Tanzania, where MetS is ...

Post cover
Image courtesy of "ETHealthworld.com"

Akero's drug helps reduce fatty liver scarring in patients during trial (ETHealthworld.com)

Health News: The condition, earlier called non-alcoholic steatohepatitis (NASH), affects around 5% of the population, according to the American Liver ...

Post cover
Image courtesy of "FierceBiotech"

Akero soars as liver scarring improves in longer MASH trial (FierceBiotech)

The 96-week data link FGF21 analog efruxifermin to significant improvements in liver scarring in metabolic dysfunction-associated steatohepatitis.

Post cover
Image courtesy of "OhioHealth Newsroom"

Prioritizing Your Liver Health (OhioHealth Newsroom)

With 17 years of experience treating liver cancer patients, Arvinder Bhinder, MD, an oncologist with OhioHealth, recently shared with Parade.com how ...

Explore the last week